.. . . , . ....... . ...c. ..uJ ‘ 14" .I .... I o
.. . ue in. H1". ......»mPaqu. “fig“?Wu..h....1u~.t.&.auww..mww.flu 22.4.35 ...

. . ...-.....- ..... . . . ...... -. m ............N, 36...... 4 . .r-- . .- .- .3 -

.. . w . I. ....umcu...3.ww,.¥..v .....IJunw-v- ....Wv wu. .r...a.ow..54$w.. #359... ..o-(QNHIIH o 0“” -13.”..JWWIQR .1.

. .. a... -.mrfisms a.w.....m......¢.u...m us... .....iw.¢..-..3. «MU-«$4.».- .._-... ..-.A..u....--$. fiuuwmrlfln r ..

. . .. . . “:53... ..“.H..._-..w.,.. .. .-....mw-H.”.51.”...___-5..w.h-fl. ...-an 9%va.

nwfi-wM-umuhdmxfiswgnw 1.1..

      

.. J} J... .- f
w. .55.....-

b... . ... GIWVI.‘ a
unfit. .o . . .sf.
.II V . ‘V -

. K . WWW-Ma...» gum

h-. V.-

      

 

 

 

   

 

:' -'

 

. .1-
Ox‘.-’..d;” ;'v
«213,? "T?
s.
P . hs‘ -
a}. . 3:
.545. . .
“5" 5*
a; 3
r In C
5‘}: 5?
~<... g

’5
F‘
5:"
.r.
_. :3.
l
9"-
£9
:3:
‘a
.0
t 2"
6c:
0
't
't
4:2:3
$4
é.
4.
2+
V

 

‘33..
I‘Q‘d‘

J .
"£55.
‘33
;- 1‘54:-
._ ' ‘4 .-:

' t'

. . .0;

in

I ..

‘3'.

”3.5

“I

I. .1

- I‘

.I':

«g

51’

4:3

a?

.3:
g 6

Qt

 

 

 

 

 

A.-
_ :5?

 

  

 

   

 

44, .1“: H
. .§ .. .. .
I .~.-H1.o.9.. I

 

. . n
4v.

   

um.

 

.0

.I o. . 1.1.“. ..~ . In \.. .H..:. . ..... ...... . . .- . ...... .I ...x ..

s.ww-...u_.nx.w... Lyra-.....mnmefwwmmm... "3:2. din-......sflwys .5»: .. w. 2....
. t o .. . If. .a . '1...) to. ... . .. .. t
..v-ww» 55...... “ivy“...e: M . .

     

 

  

. . . .I.. u. noANmMNu-‘ufi-II It... ..I .ou... ..m. .II:..... .
. .. . ..Idp uwfiMfi-Wfiarfiy ,. L.I"TWI~WwHWIm.n.vyu-rnflum 0.45.... a
.. 33.1.. 9-. 1L~.fifl.. r3... .. A9,!- ..c.....:.M.v ‘- Ix. Ibuwb}

. ivy-v» .L .. . n.u¢"h-~1¢ 34.2.. .4: aux-.{amnI Nov...” sir .Jf‘VflI w. I“ . .11.: $3M! ..
Q . . . .5 .... .. .. ... ---.. . I. .
5.3-... w... ..u,.......-,.-......- Map-3......xan- ...-...... 5............... 55...... ......45. .... .
. . d I... ... .. ., . . . ...(w......... .5... .....w... a In. ....-. .. :er u?

.4

  

 

 

 

 

 

 

 

.4 52: 5
I? v:
A C
It ‘i.
r a,
_ (“‘9‘
N ,0 '.
. .
.4225
3 {1*
‘5',
0’ .
. 3%
.— Iafi: :' ....
I; ‘f' ; .‘
JV?! '
2‘"‘.
:«4'1
:5“
4-. J‘
8 i
O, .:
t’ I;
1’
5.1“ 5
.... 1
5’. ‘9
' 5
54.,

  

 

 

 

    

r .

          

 

 

 

... x .. .M ....
. . a: ‘5 .5 1‘. a . .
v OId’flatn‘ A . . I ( ‘r-o‘.. . “(fifth-.0 . . . v. .’
. 0.1.1 (1 . ....I It...“ ‘7‘] k «’0. A a a.
1.5.... . . «5...: ...-1.. ......dfixww. us.nn5m#o....v - - a -
I... .. o f I .Q 1...: t. 1.. <.I. .a. n I..u
. a“. 91:09... ”9.9:. . $3.37... NUT“. . ..I4.-.n.-....L.... u.-. .2th
...... . ...... 1 ... . - . I

 

 

 

 

      

 

  

    

.... . ..
f. o \ Pvrnvgi‘ ..1. .

. , .. . _ - .. . m
L “...“... s... ._ p. $55.95.“... ...-5:. .. ... _ .. 5.4 3%..

I . -. . ...
- . .. . .L .mhmuut‘wofiw‘ .v.
. , . 1%,? .I .lmt-WW-Ou-Aaucufl “~wa ... .. MSW-W.
. 54.55555 ......

@555553. .

....v
.. .T
‘:n.

qulef-u (-... ....Ibcvr..Nl . . wI} .v ...-hi . n A c ...

. . r.. .. ... ....m .118?! ....V. hII .....In.... - .... . 3% - Vs a u u. .-

. . . . I. ...”.hflqu H.- In”. wr$.d.wf%l...ts.-vkvnn0n. A Io..u~...m.¥$x . u%.£..ruf w... ..Wthufiflfi:
. . . ,. ., . . ..r. ..v..-.. 1.. «Icon 4 .4 fwd-.58.» .P..o...-.-.G - ‘- 31.12% . .. ...u......-.... ’11.?- ....4a .mHuI. ...
. . . ....- h. . v9... . . . #ngEM-fuéiakr 43......" -.. ..fiUH-h 3......ffr. ....“ flaw 3...»)... .a. . ("14.2%.33 4.91.1.
.. .. )LENVWHI - . n . ...... . ....r. .. infu- s: . ..comAJmofrfi...-¢»zf. . ..- v.rm.m....7...u.1..~w.«h: .u u........ Tawum’u .9. own-... at}: f
...-MW? .. c .- .rcv... .um. . Ind-«Ke-nfi‘oé .....J.....1I.p.. ...w....w T.“ I.“ . ...:n. ...u w . ......s..._o~.va.v..a.on.‘n..r.. ...m .. (...-rxvnw...‘ 3.1m».

it ~ . r». 0'... 0 ~ A‘ n D \\n v ‘n.‘..o0."}.4vv O. ... ..I ..‘- |..|-..DJVI. I”. 32.? Sfil.| 4. 1‘”;va .6. ”It... . HUI .lunw

     

I"
a

,. .9 h.."o" ‘APWLP’.¢¢.

 

...:w

arc-:9 "

          

    

I I‘-
l 0-.“
‘
. a.
4+
0"
‘5‘ -
I
..q
.3.‘
'.

f ‘1’“
‘-
.15-

- A;

O
33:;

ll
'1
R:
V
‘|
i
)
IE
‘1.
1"
..‘1‘
".6
v v
3.
. G‘
R‘
0:!
, .
a.
i
4.
c l i V 1‘ I
. 35 ‘ .
.. ':
9'."
u- f
’4-
Q. ‘E
I
'g
I
a:-

 

 

 

 

 

....».- . . ... no . ...v ...
55,: ...... 5.555%. .. ...--

.... .. ......V , 3w... 79.- -_--... silvim. ....

...; .... uh.1‘..~.vr ..v '11.“ thfiw'I'l-Cwl... .0 up, IV

... .5... 13 MM». u..- «fl... ...o...r.. 15.24... it... .25...
2...)... .... SEE..- (I... .91....
....u.-........ 55...... «...-9...... 5 35....» .. .33.. $3
.V.II\?.€~.- ......w._...-.u1...m .5 ......NBI. 5. .... wt... . .
tq.-‘d.r£‘.*ona§tdlcl CI 4' .‘o’d.#.u. -& .
. x... ...... :5. . .....(acfix. ......

O.Iu - ., . .ufllfl?‘ I... o. ., Mflxav .

.v l(.«..r1m-Q.. “5‘7 .00: ..Jhr.mmuuhntu‘5.r-CA. ... ..

“m" be... «are? «......A.ro..,...,..-.m-.éuwn

 

O

' I
II.“

n
gfi

. - 3 ‘1‘:
5. w

-' .’..'
.1;

"2

\

49
x?
‘1.
3;.-
‘0

“2

”-1
J.

‘1

'r
f
,‘I
0
IV-
uI' .
.t‘. ‘
'..§§5: 5: .
I
it.

'_'.
.I

ta.
{‘5

r:‘:a"

v)

.3";
F”!
£91

A."
. fir. '-. .'

’I‘

It:

‘74-

~-

7%..

#2:

:3

1'."

 

I

1
.1
t- ‘r‘ -
£4,
.v'~.
,I‘1
5.
:3
. '1
~-
.
3:.
I f
1‘:
Jr
'VL‘
L
O
A

           

 

 

 

. 555555.... . .5.

       

 

 

   

.. - O u . 3». fl -.-
. ..... u @- bJV “.5. .. July. .. IMI ' ,. . Igol‘ .vtvu, . - ,, I: i .1 I
. ., I” . ... - .. .. ..I I ... .. I . no .. nun: .. ..-. r In. .... v . A. I .. o ... . . . . . -
4s . “m J4...- J§E-.U.I,mu*.”w1a~u«wufl«map ”w ”~va .I-an.4w|r~ 4mm am “My”! ...-fin... .. .wp’Ir-IWM. ... 1w”: AW. ...0- . ca «.flflAka-Vnrafluu- ”0...... .3»..~v.~.1.%.§. .\......IH-h. . . .
Ant: I ..I u I rt u V“ II. I ‘ “4|.” ...l.-.-h...-.I\- v I C- II I. 8.1.! 4. HI. ...I ... ... fl ..Inm'I. . ... . I L . v .. .... . II: a .. -5. ...-
yolk”. Jun-5.43.3: ..wm.» Jr “‘10. {$55.1 I‘Navmw..qt%wfidrbu~{...“shflllflufiyfi _ ..vm«mmoaumflwxflohmnwfihcwflu[Va-HHWVHWJ...“ WWKJTLR-WDI... H...- .r... am .-I-. «kaJ u ..
....ukm-utwa unr. ...-..- . . .1. .... . .. ...--.. ra.....W.....u.-5.ms.1mw£.,-..~............. -mh......,..v§....3-.-.n-u..a ...... Kw... win-n... ......s 4.. 5.9.x .... . . . . . . .
HmIo-Z- s -. Ir fax—FA.- ... . .. .3 5-427 .. KIWI. . a . . ”I“ 13‘-.. I J! r....« ...r : . - .h-wfilo . Maxi... ..k.w..-,. . . .. or.»- ..wfl.nww-Laru nu... .1 ...-.... ..UJ. ....uo..... ...»... . - Irwin. -. 5.0.... .I. .v . . . ,. «HY-I. - .. .-
.5- 5....- .- 5.13..- .. .....1. . . .. _ . . . . 5- ,- . i5... $5.... -... 3...... .5... ...-5...: ......
L .0 . - . ka.&sam.udhkmu.v .A. . a . r U“ 5 .....t... u ,. .wd svvor. MARI-:11. -..... .‘¥fo»-a. .3 n .-.- .
. a -. ...-I. 05.! «on-- l..rl ..- . . . . . . m .

 

. 0 tr .. .0 W. ... .1. . .. .. ‘ -- . .5 9| ‘ . u- ., . .... . v.
km.- »riDMr-Ht... uwmrwblfu «INKHQJIHL ..uiu..&.4w1v nun-usfiu...Wu-.m.mw..o....v.tws..,n.. TI‘M. . ... . I.
.- vM..-Hn.¢at...l.fvu.m ‘J {M . -. . Pr. V‘.V.H u?€»IL.JQHaIH‘:I-hrf1 .OIWWHWAHQ .-.moa¢h VLLI . II. . “Nmyonm . \IJIMH
.. . . . _ .z- .. .m CT..- . ... .- . -. ..... .. WW www.cuwfikvfilrumr....nn-r..... awash-rise... 73. «fit-.... ...... ......
. _. . . . .. .. .-.-.......... 1. 5.33.... . .... ., .«fi.é....-& ii)... . ...-5.453% .55.... .. -. 5 ...-5.... ....
. ... ,- fivfl-Infig 1.“.Tvlé.q.fi-w. ...»? ... wt..." .35..“ . .Tfiq loud-5%.-.-Itfi rum: .. Sac-..., our" ink-031+.- .r. uh... .W... Icy-3&7". in ....L. ”Nth-H"
. . 5.... ...“..mwffifif... a... ..55w...¢....€. 55.5%.... ”...... . 3.3.. ...-.55... 55.55..»5v...55m®.w4 3...... .5... ”5.5.5555. if»... ...-“...“..-
. .. ., . 3.3.1.4.. . ....c .... .. . rah-h... .ltav I“. . n ....I ..I-\§..m.- .5391...) .... .. . . 2. II... .1...- ..-1. I... -.. - ..ur .- .-..oa P. ....Qw-fvtr $1va . . . : WI... .
o .. . g“.‘¥uo . I. ~.- A -\ .a .fi‘ : ““bna .0 a vial!” r .‘tM‘.-' II . 1. .W-. INI- I-.. VaritaWIr-“pr 0' ...H( .N ‘P‘awl -. on ..I --.-\H-o' I a o . M‘.‘ a .. . ‘5 n. H u C
. . ..u 1.,- . I , . _ . .. . J . . .tI . I? II.M.J. t1 .. .I .7 . I. I- I . o I.“ .-. -..-... i M: ....r . .....l' I -..-A, ..- .C ....or . . W‘ I” ....O... 1..» 55.; . ...- .)3 ~11. « . “n . .n
. : I... ...... ..,..~......-..... a... ...-5...”... ...-.... ...-...... ...-v1. 5n»...15.9....“...»..wa...-......ampvffimfumwwix358W“...5...... mm“
‘ I Q s . c . l . ..1 . I . I ... . I . ..

h AUWNW

n by .

  
  

  
  

IVA-in, I. I“.

 

 

9
.A' ..a. 0

...].II .av...o~.....d hxudrht- L h... - v 14. w... . ..- v n K . z
...n... ...ubin. ... - -. IU.I.-¢J\~M.§r .4 "r...- Infi. . ...-h.- .. .5. .. 5 ...u ..c: . .w» a _. . .. . - .. . .
.a.-._.xm..r~o emu-v, -.ummwuma...Nflwflrauba.¢.u.....-....n...,..-. ,. 2. .5."w..m_.-m.wfira. mum-XV... ...-mrmhmfi. fiv...~......mfi. at»... . .. 5. ......w: “my”...- wax-...».
. - . . .. .6 .... . ... .13., L. 4-. 5 .w. .....-v....-..9.I..- .......- viva-...-.. I , . . . . . .. .. ...... :- . .. . ...
P- ..‘. -... ...¢ . ..Vpbiplfwxfllu- 7 . “wank-1.».- r..-.. . ... ... ”a. . . . . . .. .. ..
.p .I) II. . . A O u . ,III I . -10.; . . < l nolIx.. . ...4~ . . . _. 1 - . .
....WH .... .4. ...... ”...-.... hum-WW uh...».......v..fi$.. 3.51M“... ”......er 15......- ..w.... . 5-. 5.... . . .
. . .8......-......... .4. ...: .. ..- a... .- 1...... ... _.-.. .-
.. - .. "(IJL‘ rip: Trlmroumvaflwvf IJJMJXIJIL-J-m” ......MMCWUuw-U ..1tté.w s u ..wdh3‘?! ....hwh. 2x7! -w-Syniofi
. hen-t»... a? .....s Hug w... ..I. 3.5;? . Ww-r..-..3T~..-7«ns.md ...-..r... . Aw. ..-.8 . . . ..
. I- . ‘. \a" 14“.“5 .in: .. ' .1. .I F‘ .O a.?{.\.o \ .NP‘PI., ..jt‘hlivrmdl. «II.- f. v ..flw a .
._ II. . . ‘0 3.- AFN-...: .-.l u Sock I W é. .. . 5...... 9M. nab??? . ..
. . -..-.52.... .... h :45... ...-5... ...-......5555551, .- 55.55-... 55...? - _
. .. . ...»..Ig ...... - u .0“ up I . HIT..- .... ...-v... .... . . um: . . . . . _. _. - ,
..., 3 .k aW-RL.1.(-o.4. l .. . ...-I1. MiG-n H334» ...I . ,. ...-at.Mm-C5rx..a.IvV-x (Ant-... . . 4 .. I p... . .I .... _ ... . ....ul- ...-22‘ .Lfl. ... -
LI‘SLIYIOWAMI “fizr. . d..k~v.*our~.h.guuflu.4.l~.fvn&o \a.¢|uuflnr~.\«flo..x|u¢.mw. a..(:bol.¢fl\“.“qmau . .....N “W? MLNrnmquMWUMrmflu’fiJ—fi « . l.;—...h.w.4.WVM-li- .‘a.U.O-u1.... ..It-IIWNV .
- I" u I .I I .u. . 'v ‘4 "!..0n od‘ 7 .. u . c0 .auI. .I .IJ. ... II I-.. cl: s ...1 as . . . . .
...“...vnoméwvna «hymn. ....rw...» .hvflwzuu: ..Mahflfiwxfiwk ...... Wm. x».......¢....~... «...... .47.. um I”. .... mgr.-n.......wu..-... ... . .. .- . . f . . ......
. T? ... I .1 . - ; . -..-«29%....3 flow-”.JJIVHQ .r;1...?. .... . ....H... ad...mu..v 5-.vmvu-Hu...u... . . ,...(.h...-«..Mu.4w..-. mm - ,4». r ,-r.,.-.....-.....v.r. ....“v... flat»... ”....u... ,.

II I - . ~ . .

51...... .......thfiwwuwwwrfiwwfiwzfiwwwwnm.....u. L.» - ......m 55.-....» “wit-5...... , . .. .
£m$rwkmékfi -....w...-...w$..,...?a-u -.....r.”finififimwfiv...fim.-...........-...r._.r..-m l- ...n-.._.-...,. nun-.55.... 5... , .. z... ......- --....-.... . ,. . , . - . .. . .
.. Lu .. .x... .. ....- g? «-..-..-...tufir.......M.....-.....w....e5._u.r...5w. -....muw......?%-fi..mz.~...-M.. «...-51.5... ...“....w»...«..,..H-ua.mmwn.“um-"55-...........Mm...t...uu...m.m.mfl ..w...-...-...........Im........m.~n.......unw.nuw. u;.5m..w-n....wrmm%.,&-.afiwgnwfiava u.....u.H.-..._,. . u ...-“m... «....vw..J- 2 m

_ - J .. - u a .v... 7 «an... £3.- L. a I . «...: . .... lxu flux-m ..u-WohIL...-...JuuL-u. ,Mr.....%+ou...n.fi..nw....z.nhw. ...L-mv.-m.1.q...-Traumkfflmmfifimr..w1WmIW..n~HurW.Umht\-wmdiu- .wW.J¢M.fiAW-u.n, ... .... ....
. .- .- .- .. ..-.z .... ...» . -. -.. .... .- ...ufidrf. 7...... . ..-.. ...... . ...-.....mEthwm-Whvnfit. ...

2.395.... ..

 

L . ... . . I). “W ._ q -.I I I I l 5‘. a .
Lil-54k rai l-Jb 1.. “1.)ouvl ...- t 11 .QIInrJ 3.31:1 ..lr.‘ .l t- u" I . y . .9- ..v Jfi" I - the .... L . CI NJ”: .- 1.; . ”0:5.“ I
. _ . a I. . .4? OJ . ‘0. O . . [.013 5.: I. .‘t . 1 n .. . 1 .. ‘. .. I u ,I I'- I I u . l. I 9 .- I
~ A... ., \TIT.A01 .u. w .... ... h...- . $431.4 ...-fr... ..I. .~ m1”... ..vthm .--..-I. fw .....II- .MVIIINL m LI-IinJo ... . .. .. ...-.42.... . o. v .w. .1: ,3 2-“ I . l
m - . . . ...-v.59... 2:34... .....5........c...«--..u-?(- ...... ..........-.....w ...wa?...-..-..u. .... A ..-
. . H ...”! .. l-..I--. .. . I‘D. L IVAN-lo. . "run-7....(l v.4! "Hr-.0 v! I. fioh .... J . ll.
. .. ...” . .. n . I I . . ......i a .... . . .. KI ...! M l .

                             
                            

 

n I_‘
v I 1
J;-
4'!
I
4‘
is
.‘P
'3
u,‘
I
I
0f
A4! (‘
. '. ' 'g: . a
-~'fv.. '
, J'-
a 1
I"
I l
I
r. f
9.1"
G’s.
U...
I
'0 9'
'2']!
9%

‘ .

:1. '.
Irv '

‘90,! .\

it :
r}-
«r
'
O9;
3 7- u
H
C
I"
..Q'
'I
‘
“‘
., s‘
. 5‘
f :7:
J.
§
1’
‘Q
.‘I
5-
5
12‘.

”In I .
I. .1: ....”kfl

or I I ‘
n...~..1 ....-.o55...... ....) . .....-
. ‘1. In ML.» 3. . .r “a T 0* wfi~uhflwot .14.“ - ... 5...».99VI5 «Jul..|...1..1.u' v. . V1.30..- .. -. .vv . 6 NW A
v... 1.. .. . .. ... . _ ...-.-. \t . . ... ..s.
I ‘ u I .
9

fun:
"
‘-
u‘.‘
9
1
fi‘
."..
"ado. - -
.“I
L
l.':
" I

  
 

 

_ . .. n. . . ...
.. . fi-o .vL Kc.)- .E-.L [vb-a . .v .V. . ...-u ...
\. Iv . k. .7..an .. I. .....Lul. %“..A . II... \...N . h..1..- »r ufl‘ I‘Mflorfinmn -. . .... ..--I .. ...v A .L. _ .. .. a v . - .
5.3.53»; Sash; «Emu-...-.. ....ww... Lv .M .. .T.M...r..n I... «M4 .5 ........!K.J...-Apxw...w.mn.n.-w..h....uuwwfiflwwum . "3.3.”... w...“ . . ..m. in”. .. 5.. --.: 3.1. .... ”.... ...... . .. .2...
”41» I. .r w;- J.\H ..0v 1». ...mrflvt'w . «- «rm. U ... ovt, - N9...» ...-3.11. . '12:.5. «Ira-Q‘, ... ... *1 . ”6.519... «.1 1....Nw. \ I or. .tuv.. - .4. ...-..u .u I.. .. {av-I. 1. .IIv in: .I.n ..l ..a.- I» I . ...?» .v ... ..4 ...H. II \ I . . QI-v
. ......I‘u. - .. . - .. n“ h f . 4 I x - >9 0 d“ {H b.§.LI~ ... 4 . 2 lu..m~\' .M. V 1.... . . .. . .FW..I.?.J.I¢' fi‘c . <. ..III. “-0. £9 x0. 45. ”an...“ I... O \ . ...I 01 l.9 I.I\l ... . a .. - I r\. .0 I I u (-..-s W .51. «4+. - -n ( t L
.J- . Ir .r- II... . 1..l\r. -. . I. I6 .. \L I -. -1..I. v..L .kd up .1. .o ...-I». - . .... -. . . - ..Iqa V 1.a a v .v‘. I . . - ..J. . 04... 1 . H.
..I 1 o 9_. T'JWIV I. . . 1.9.. I” 7-1.. .. . ~.l .4. .MN» . . . .«I. . - -. O” . .v .\n .o I . IIIIV. v‘. .‘ . . .VI .3, ....- .JI . ... . N, .24” '.C Id .§ v1 ova . L . \Hv M‘XVI‘ 11.3 p u .u . g.» A.
...-unxwwz.» . .c; ......quw .- w... ... ...-....mh-«Qée «ungmffiw-mtfl-mmv.32. .... ... I... .. a ......- .. ..«..JT&«V¢-..«V,f...¢.m.n.rchm. .v. ....w. 1. -..-.... ...... .....4. Turn. ...-I Jun...”- Hr .- 4 .. .. n.5,..{11u7Wn ALI I.\.I-&-3:..Iu.H-I~. ”...-NH.
.. . \ml- -..Mw-.., .. a I... .(4 ”5...; - .... .x...,. .c ... ~;.Iv .wu {uni-1... .I t. .... .. H... ...... ...._.......o.. .... . .e . A. . ., - u...- .u .....-. . ..aI-...-.- I. .I. .. 1.!- I...:.::. . .0-
.J.‘t-L .o. I. (V? o): 44'. fl. rm ”U .V. .-a.lp s... » ..o1.l a “f ..w.‘- ' ...... .9. ..ID I.» .o: ..I! o. 31.0.“...3. w. .... I. . .ov‘f 5. ..v . III)..\ :1.» .Iv-W It- 1. I; u I OVLLI .
.lnrvl - c I 0-. o t .u «.... -I‘V . o ..l "11.. ‘W {5 ...-Wu. .. .....hct o vcwsugcfli...iul3 . . o . ..4 .r“! .IcA.‘ . ‘90. l . .. . ‘I NIB-... :' .. I - a . 5! VI..II "IN-I.- . 1 .0 Q-a F- .L . m-’W J 5.: .f I l... . . H a .“W?Un II \.
... Jfl+ufi ..l.\.«. Ibuv. .-L. I ....I. EA. .I . - - - . . II... . “u I. I. 1!. .- .I .-. - ... .05 a . . I .. 3.1.421: ...-.1 $..- . 5 LA [Ina-1|: w. I . ...-......Ktr ... I-’ .a.... .r . . I. 3.1- «v. .uJ . on .o....c.J.-.ur‘fl Hui“: gap“. . -. uq II. .
‘ ..I.. . .. .41. ....Ix. fat-I- NS. rum.-- - v. .u .gva ..u... ... -I.... .Lri‘f ...-er.- ) I p s...“ ......l-prl. 3- III- ....) 1 ~Jo... \- 1.“: . \ .. .3 ,0: - .. .I v. -- L . I I . p .. . . .... .... \..r..o.. Ir .3..- .. . JIM-.4 .. p v.4: . I
.1 . . - 5 . . I: v I- I. . .. I. I I .. .... . . .. . . ...N... I . o I. ... .w,kI-./,.- .c . . . 11' -1) I I .01.! .t. .II n I... .3. ; .I" ha I .- .
«I. . chug—o. ‘0 “...! v J _ -4 v. 9‘ 0.4 .N Rah v1. . \ I o 'v 0 a I. .. II...‘ cWfi'u1 & ¢ . o u 1‘ \k“ 50 I4! V a a 0‘ V 0“ Il.n . I - , I - I ‘\II I I u o o I. . b I ’fi. I.-
. L- .... ... .. . .- 535?! .x.. - - .......¢..... .5. . ._ - _ .. . 3.5... h... .. . . -., .. . .. c .- ... 5.1.5.5 .-.-.. z...- .. c .3. 7 .. - .. ..-»..m... 5 5 -. . ..- L...
3..-... a...)- -. .5... L ; --..w.-.uk_...-4r:.. 5.5.7:...“ ...-......u......... 5-... .... ...... -... 5-: 54.5%,... ... ....1..- . v.5»..5._.pm-..... . 55-..”... ..-). -....Lu...... ...-.5? .5”--. -..4.-...........am..nw.w.. .
. o - n I I III II. ‘ \. I. ‘ .~. ! I I . “n. I I V. - I ‘ H II. .‘u. l_. II! I n to. HI. .0 ..QII 1-0 I I ..v I. A ... .v.l. o—k-I 01:. I I: .I. I ,‘Q . “I .. .Int‘. . u v . I.v-. .-0 - I.
k 11 In . 7 I . J‘k Ll Al (I! D ..VI 0‘ (“a t g . II I. .- ... . )7 s. .. ..Vh.‘o o 1 . . O . .. o o . .-o\I Ix! I. \I I . ' a M I. 6‘ FH-‘Q .. Ay ...! I ‘5‘ ‘ . .
I.II~\ rd .. 54‘ It ‘0‘. t I I ._"..ov..o& - M r! K t 9‘ F.‘ .4 w . k-OI I ’. . ‘ I r. .. 0‘ - _«. .. I I cl'.' a. r I -.V. -. I - ' g . .-I I» I I”? 1' I) . \‘Q 'I\
...-v...-r....A-r ... - A ‘0....-A .v..' . .u -JI. . .. I A! .. . .... . - ~0- I. .4 3... o )1; . . . :.. ... . v1 .. v, n.'- . L...- . .5 . .1. . r-‘u.Io.-..-..I- - .-. . I. I. . «5 -... I. 9., ..J. I . on
1: ”Judah-...... LIV-av...” 5‘37. .35).»... fay-“p.325... .1 ..$:NP-..- -- .I riinu “M .u 5%.... ..:.-m..N ...- fuss-Ha ... ...-s wwxfiwumfl ..rh . 15.- ...-.. 3...... \ .o-«u. .- .mr \ .. - ..vo - n. ... 1.9.. 4. .. . .Mv.k..¢ v.6...“ IJJIIIUAMV ”.....LIL 63.. Ion-RMID ...J-uahflfim ..Mw
...! ¢ .... .. - I . J... .L 2...- ... ..II ..I-IVIT- ... I o _. nun.- - .... ... .v. .. .5- I. ., -....n..u.-..VV ...-...-- ... .... .. .... - . 1)...- o.b Jyv. . . I -.- I .J ..\.- u-. r... -. . I 5|.I'.. . .. .I- u. .
tr; ...-1.---.-- . ...- ...... . u..--.;-... : 5.. . Fa.-. . . ...). - - - . .. . .. -....f . ..-. - .. .. 5C . L..- -- '5.- - ..p I.--
moxflu 5.45.3.- . an.- GoN . ......u qu.....£n-.a.. .Ivv.»~.-...-...- ...-412. ..r. ..x.x..,._..n.w... ..vwwv.....-v- aw.mm.zr.....lu»1~-t.. . - ....- rn ... ...-...... . T -.. H...... w. .. . -.r-...h- .- ... 1....J. .9... . . .m. a. - unto-(.34 .... .- . .v.-.«.5.. .-.-flu..- Lmb?! -..... ...-.n
7 -v.. I Y. . ‘60 II - 0- n ...K . . . I v .u - 5. v I . u w | l I .o I I. I.- a I o I -.., .. u - . . .-I- I - 5. 1 II 5 I Y. I- . I o ..l :- -II. I. Q It“ '. .c I .II. .0 \ I.‘
v. .9? “VINO. Inn”; - g.” n. u-Io-uv- r ..I«-.....om..w-L .u-... 1m.”..ub.0.\vfl..- .... v. ......S .«O‘r-n..o~. «up; aw, .1...J.\WII.F.H\~ u. .I no -.Ur: . - I .I at“ you -\I_.. IL r .-h r. I a L .1 “a... If Ia... .....wa . o. It . I .v.NduI.or a. .quIu . .n-))\-|v.-..| I“ "we .. L‘I . . .wI
L...- .-... . ...... .-.-...m..1.-.. ..H ......U................--...... -... ......4.L.7..r- 5. .. ---: .... 1...... ...}. ...- -... mania»...- .-.,.. .- ...... ...-.-..-.guh- . ......I .. .fl ..1 “an-h.- .. 9.1.5:. he - - - ... - .A. _. . .
I . Io ...l v I. . I-. 11...... I. I II.. .. . I .n u. . .- \. I l‘n .0 lo I I I. -. .‘4 .
.\.1 iv -\f-a..\ul Nu. .. Idaw WI. .| I ~- .~ to. _- ..- (I ...,"s . c o «In-... .a. .. -....h!vLI\... I.“ .. I .. ...... I v! n u 5". L .... . u .? I —. _ ...- t..d.* v... JP. . I .v .. I. .m5 own .I. I n - Jt- .on I I...) 1.
ol- .., I v .. ‘0...- .-. - 176 o VU‘YC ‘3'"... . . . . ”s . .. ..I y‘; .223... ....I. u .Luou‘cx . L , - I: - I. u . . n - u. .hnh. . w.» . u -c . ..v I o 4 5 » . . . J o 5.9.. .II 0 -. . . .I... I .
... .I - ... ' I ..I I. I.|.. . IV 5 I ..av- .om Inc I-.2 ... . III I . lo. I - . I. .... .I . -l.( 1.. - u . - . . I .II.\ . . -0
..\-n..PI-.....’ Wants. ( n-«r.1-uh.u.. I - at... A. .u ut-,.mw...$ fins-”mama. 9V4. . WW- ..I .ro.‘ MIA": ”11.1..Hv .. CHIN. .- .1- .. .u ...-1.. .v; 3. I n. .m .. ....-.r ..uv . l Iqoor“ M\ .3”. . rJP.' .fu.?ao). w n? I v.1wu3m O .n s 'g- .11. o5‘. 3
. ..\ a . - .I I! . o... l . ..wh o II. c.... ...UJ. . ....I... I I. Viol-l. . . . .v .. . .. 0.0:. I5 . . ... ..Id .I . , I ..I . ~ I It, .. n - I I“. ..l IIIVII .0 . . I s I I - A .- . I. ..\ I
-. m... ...‘nau.-\.w-o..u. _ a .... to.r.x-lI-.L-I.. . ...-- 00.0.!»53n- .. .o?.nc.-.v.v....n.ur-. .. ...-q. 59......) «0.. 0.5.? -.... . our? .... .....-.-.Lw-_..-. .--1. . ...-“.....mnu ..-..m. a... - I. ....Iv. ... .... -.-I .. .--.F .19...
. .r 5.1.. . . -NL ..A .. ..-. .. I o-.-.&9.I.u'.u. . .«o; to .I- I. #3-. . .- ... . ..o ... . vo.n.n:! 4 0V . ..Iww .-.-IcolvVI1n-
\. . r . .. no.1. . .u..tt ..«1 r - n- .- . .... ....osLnMu - .fi _ II n . .. erM-fafnrcoJ- w...-.. . ..... Hula; (Wyn v. u - v.4 . 9.. mun-1P. .II ‘7. v. Ix. .0 {-1- ....\..Ia lo.
- . . t0» . ... . ...-.... ... - ... -.- .. a. v r .l. . ...-J 1.. - o I .- I - .o -.. .r ..-I. -. a -
. . . - .a..' Q I ...-.733: . s .v \ Y'h'vhnrcru. hw.flsun.lv. » .. !!.. "-In....-.I.r o .m’IVvl.o.Hq-uI-I-I.0l.~ .q
. . L - . .. .. .. I .....- u..w ....IVJLT

 

: I ..s‘ ...-d0 5 II . A o . ..I o
t! V‘* .i "xv 1L ‘— Q] a ’ n a r"..-
‘. A I. Q A ‘. ‘ I ‘0‘ ”I
r my a.» r... 1‘... ~t..\. If". ...-.5! 0.)! u

I. r D .. . ,
..NOIMI-w “N, .r.... o"?’o.q-l‘ . ‘49Wfi1

 

 

 

LIBRARY
Michigan State
University

 

 

PLACE IN RETURN BOX to remove this checkout from your record.
TO AVOID FINES return on or before date due.
MAY BE RECALLED with earlier due date if requested.

 

DATE DUE DATE DUE DATE DUE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6/01 c:/CIRCIDateDue.p65-p. 1 5

W—

CRITICAL PATHWAY FOR ACUTE OTITIS MEDIA IN
INFANTS AND CHILDREN (AGES 6-36 MONTHS)

BY
Maya Clark

A SCHOLARLY PROJECT
Submitted to
Michigan State University
in partial fulfillment of the requirements
for the degree

MASTER OF SCIENCE IN NURSING

College of Nursing

1996

ABSTRACT

CRITICAL PATHWAY FOR ACUTE OTITIS MEDIA IN
INFANTS AND CHILDREN (AGES 6-36 MONTHS)

BY
Maya Clark

Otitis media is one of the most common pediatric
diseases. Approximately 7 out of 10 children are afflicted
and this includes children from all races, ages and social
groups (Bonadio, 1994). Acute otitis media (ACM) is the
most common specific diagnosis made by clinicians treating
youngsters in primary care family practices and pediatric
settings. The highest incidence of disease occurs between
the ages of 6 to 36 months (Bonadio, 1994). Complications
of acute otitis media and its sequelae often affect the
child years beyond the original infection in the form of
learning and speech disabilities and hearing deficits.

There is a need for consistent, holistic, low cost and
effective treatment of acute otitis media in the primary
care setting to treat the initial disease, establish
continuity with follow up and decrease the incidence of
morbidity related to chronic otitis media. The purpose of
this project is to develop a logical, research-based pathway
for practitioners working in primary care for infant and
toddler-aged patients presenting with uncomplicated episodes

of acute otitis media.

ACKNOWLEDGMENTS

I would like to express my deep appreciation to my
committee members for their patience, support and invaluable
guidance. Thank you to my committee chairperson, Sharon
King, and my committee members, Linda Keilman and Suzanne
Budd. My gratitude is heartfelt.

I would like to thank my Mom and Dad, who have
tirelessly supported me in all my endeavors, through rough
times and in times of joy and accomplishments. A special
note of thanks to my husband, George, who has seen me
through my entire collegiate career. George is my best
friend and partner in life. May we finally reap some
rewards for many years of struggle and growth. Finally, I
would like to express my love for my beautiful and precious
little boy, Ben, whose birth came during my graduate
education. He has made my life complete and truly

meaningful.

iii

TABLE OF CONTENTS

LIST OF TABLES . . . . . . . . . . .
LIST OF FIGURES . . . . . . . . . . .

INTRODUCTION . . . . . . . . . . . .
Definitions . . . . . . . . . .
Project Objectives . . . . . . .

CONCEPTUAL FRAMEWORK . . . . . . . .

LITERATURE REVIEW . . . . . . . . .
Demographics and Risk Factors
Physiologic Description . . .
Microbiology . . . . . . . . .
Symptoms and Physical Findings
Physical Exam Findings . . . .
Treatment of Acute Otitis Media
Current Recommendations
Duration of Treatment
Treatment Alternative
Referral Criterion . .
Prevention . . . . . .
Summary . . . . . . .

O O O I O
O O O O O O
O O O O O
O O O O O
O O O O C O

CRITICAL PATHWAY . . . . . . . . . .
Critical Pathway Evaluation . .
Implications for the APN . . . .

LIST OF REFERENCES . . . . . . . . .

iv

Page

11
12
14
16
19
22
24
26
29
30
32

33

LIST OF TABLES

Table

1

The APN's Direct Nursing Care Role

Indirect Nursing Roles of the APN .

Distribution of Pathogens

Tympanic Membrane Findings

Antimicrobial Agents for Therapy of

media 0 O O O O O O O 0

First Visit to the APN .

Recheck Visit at 48 to 72 Hours

Follow-up Visit at 10 Days

Acute

Otitis

LI ST OF FIGURES

Figure Page

1 Pathophysiology of Otitis Media . . . . . . . . . . . . 13

vi

INTRODUCTION

Acute otitis media is of great importance to the
primary care provider because of the huge numbers of
children the disease affects and complications from the
disease itself. Acute otitis media (ADM) is one of the most
common diseases of early childhood. According to Brook
(1994), two thirds of children in the United States
experience at least one episode of AOM by their second
birthday, and one in seven have recurrent infection with
more than six episodes by that age. Newton (1995),
presented data from a United States research study which
showed that acute otitis media was responsible for one-third
of the total urgent pediatric visits to primary care
centers. More than 50% of children will have experienced an
episode of AOM before they reach their first birthday. In
1990, there were a reported 24.5 million visits to
physicians and practitioners for the treatment of AOM
(Klein, 1994).

Health care costs related to the treatment of acute
otitis media range anywhere from 1-3 billion health care
dollars annually (Bonadio, 1993; Facione, 1990).
Approximately one-fourth of all medications prescribed are
for the treatment of acute otitis media in children. The
most common surgical procedure in children requiring the use
of general anesthesia in the United States today is

myringotomy with insertion of tympanotomy tubes. Based on

1

2
1990 statistics, there were approximately 1 million children
undergoing this procedure which is equivalent to one is
seven children. This procedure is performed most often for
frequent AOM and chronic middle ear effusion and it
ventilates the middle ear and allows for drainage (Facione,
1990; Klein, 1994).

Otitis media, left uncontrolled without consistent
clinical management, can significantly decrease the quality
of life for the children it affects. The disease in its
acute phase is most often painful affecting sleep patterns
and appetite (Facione, 1990). Long-term complications
include significant hearing loss, impaired cognitive
development and learning disabilities. Specific
complications will be discussed later in this discussion.

Acute Otitis Media: Acute otitis media is an
inflammation with purulent infection of the middle ear
cleft: characteristically lasts up to three weeks but
usually only a few days. The tympanic membrane is reddened,
bulges and usually has prominent myringial vessels. An
effusion forms in the middle ear and the drum will become
more opaque. There will also be poor mobility of drum when
examined by pneumatic otoscopy. Symptoms include: Pain
(otalgia), fever (pyrexia) and drainage (otorrhea).

Myringotony with tynpenotony tubee: Myringotomy is the

surgical puncture of the tympanic membrane for removal of

3
fluid from the middle ear with the insertion of tympanotomy
tubes for long-term drainage of the middle ear.

Pneumatic otoscopy: Pneumatic otoscopy is an otoscope
with a bulb attached to illicit a puff of air to assess
tympanic membrane mobility.

Tympanometry: Tympanometry is a procedure that assesses
the condition of the middle ear. It measures how well the
tympanic membrane functions.

2 . l :11 l'

The purpose of this project is to develop a critical
pathway for the nurse practitioner in a primary care setting
utilizing the background, demographics, pathophysiology and
microbiology of acute otitis media. Statistics have shown
that the nurse practitioner or Advanced Practice Nurse (AFN)
will see and treat many cases of acute otitis media in small
children especially between the ages of 6 to 36 months
(Bonadio, 1994; Facione, 1990; Hathaway, Katz, Dershwitz, &
Marx, 1994). The prevalence of acute otitis media and its
morbidity, sequelae and its possible long-term complications
compounds the importance of a proper and consistent
treatment protocol for the primary care provider. Following
a treatment protocol should result in improved outcomes and
resolution of the chronicity of otitis media.

The specific goal of this project is to develop a
critical pathway for the primary care advanced practice
nurse to follow when treating uncomplicated episodes of

acute otitis media in infants and toddlers, age 6 to 36

4
months. The pathway will include critical assessment
information, history and physical, treatment guidelines,
educational components, evaluation, expected outcomes and
follow up for the next visit. The pathway will be focused
and precise and will be able to be followed within a 15-
minute visit. The pathway will also include attention to
referral to physicians and/or specialists.

The pathway will be based on an extensive literature
search, where common components will be isolated and
substantiated by research. This information will then be
condensed into a logical pathway for the nurse practitioner
in primary care.

The pathway will be based on the theoretical framework
of the Scope of Practice of the Advance Practice Nurse. The
dimensions of the scope of practice for the APN will be
operationalized as actions within the critical pathway.

Conceptual Framework

The framework from which the primary care APN works
within is based upon the American Nurses Association Scope
of Practice (1985), as well as the American Academy of Nurse
Practitioners Scope of Practice (1992). The American Nurses
Association (1985), describes the framework for the Nurse
Practitioner's practice of nursing as the health continuum.
Nursing actions across the health continuum include health
promotion, specific protection against disease, early
diagnosis and treatment to prevent or limit disability, and

rehabilitation (ANA, 1985). The Nurse Practitioner provides

5
primary health care based upon their experience, competence
and in accordance with their knowledge base. The APN is
responsible for all aspects of management of health problems
encountered by the client and the APN is also accountable
for the client's outcomes, including both wellness and cost
outcomes (ANA, 1985). The APN provides nursing and health
care services to patients and their families accentuating
health promotion and disease prevention while focusing on
education and advocacy of the patient, family and community
(American Academy of Nurse Practitioners, 1992). ~

The ANA describes two areas of patient care as
delivered by the Advanced Practice Nurse. These dimensions
are the direct nursing care role and the indirect nursing
care role. The direct nursing care role elaborates and
expands upon the actions of the traditional nursing process.
The indirect nursing care roles influence the type, quality
and delivery of direct care. These roles are also essential
to enhance the overall delivery of direct care (ANA, 1985).
The dimensions of the direct nursing care roles are
described in Table 1.

These direct nursing care dimensions apply to all
primary care illnesses and presentations including acute
otitis media. Indirect nursing care roles compliment and
enhance the elements of direct care. Examples of indirect
nursing roles are as follows in Table 2.

Utilizing indirect and direct nursing care roles in the

primary care setting allows for planning and implementing

Table 1.

Description

 

Assess Health status, illness conditions, response to
illness, health risks of individuals, families and
groups. Assessment through history taking,
physical examinations and laboratory test data.
Strengths and weaknesses, coping skills,
behaviors. Environmental assessment.

 

 

IDiagnose Actual or potential health problems and/or needs
based upon the assessment of the data collected.

 

Plan Therapeutic interventions mutually with
individuals and family. Enhancement of or
i initiation of self-care and problem-solving
skills.

 

Intervene Treatment of illness in its earliest stage, manage 1
chronic illness, limit disability by providing
prompt treatment. Coordination of care with other ‘
health care professionals or resources. Provide
continuity and assist the client to deal with the
health care system effectively.

 

Evaluate Mutually with the client/family regarding
effectiveness of interventions, comprehensiveness
and continuity of the care and therapeutic
interventions that were initiated. APN to
participate in on-going self-evaluation.
Involvement in the peer review process and
institutional . alit assurance

 

 

   

holistic care and appropriate interventions for the client
of all ages and their families.

The theoretical framework for APNs working in advanced
practice allows for organized, client-focused care with the
emphasis on wellness and outcomes. This process has become
the standard of care for Advanced Practice Nurses and these

standards of nursing provide specifications for acceptable

 

 

Table 2.
0- ‘ \ - o- (0 ‘ 0 0‘ v.\ .u‘ -o . -°‘u 0 x “
W)
I Roles Actions I
Advocate Participates in community programs and effects change
in legislation related to the needs of patients and
families.

 

Change Agent Initiating change in the patient and family with
increased knowledge base. Implementing change within
the primary care setting by using the pathway.

 

Collaborator Collaborates with other specialties and disciplines for
ongoing continuity and coordination of care.

 

Consultant Consults with other disciplines and specialties and
refers to other providers according to the standards of
practice.

 

Educator Provides educational opportunities for the patients and
their families.

 

Researcher Actively participates in research related to the
clinical area and setting. Maintains knowledge of
current trends. Supports research by defining clinical
research questions. Conducts research in primary care
and incorporates research findings into practice.

 

 

 

levels of care and a basis for the determination of
excellence (ANA, 1985).
Literature Review

The purpose of the literature review is to examine
current research on acute otitis media including the
microbiology and pathophysiology of the disease. The
objective is to establish research-based criterion for the
physical assessment and diagnosis of acute otitis media.
The review of literature will also survey the course of

treatments most widely recommended, the duration of

8

treatment, treatment alternatives and standard patterns of
referral.
W

The peak incidence of this disease occurs between the
ages of 6 to 36 months, with peak frequency between the ages
of 6 to 12 months (Bonadio, 1993; Facione, 1990; Newton,
1995 & Klein, 1994). According to Bonadio (1993), 25% of
acute otitis media occurred during the first year of life,
22% during the second year of life, 15% during the third
year, and less than 10% after the age of seven years. If
the child has not had an episode of AOM prior to age three,
the chances of developing middle ear infection are
significantly decreased (Klein, 1994) . The term “early and
often” refers to the child who develops acute otitis media
in the first months of life and has frequent recurrent
episodes thereafter. Age of the first episode is
significantly associated with the number of recurrent
episodes and more-prolonged middle ear effusion after the
acute episode. Forty-four percent of infants whose first
episode of acute otitis media occurred before six weeks of
age experienced six or more recurrent infections before
their first birthday (Bonadio, 1993).

Acute otitis media is seen more often in males (60 to
70 percent of AOM), although the reason is not known
(Facione, 1990). These numbers were based on measurements
of single and recurrent episodes, number of office visits

and the number of surgical procedures (Klein, 1994).

9

Race has been shown to be a factor in the incidence of
ADM. Specific racial groups such as: the Native Americans
and Alaskans and Canadian Eskimos have an increased
incidence of acute otitis media (Klein, 1994; Facione,
1990). It has also been shown that African-American
children have fewer cases of otitis media than those of the
Caucasian race. Data is insufficient for determining the
reason for this occurrence (Klein, 1994; Casselbrant, 1995).

Otitis media has been shown to occur throughout the
entire year, however, most cases do occur throughout the
fall and winter months with a decline of acute cases during
the spring and summer. This reflects a seasonal pattern of
upper respiratory infections as well (Klein, 1994).

Other factors have been identified that place children
into categories of greater risk and potential for the
development of acute otitis media. Familial and genetic
heredity has been suggested as one of these factors. Having
a sibling or parent with chronic otitis media makes the
child twice as likely to develop ADM (Teele, 1980).
Children with single and recurrent episodes of otitis media
were more likely to have siblings and parents with histories
of significant middle ear infections as compared to those
children who did not develop episodes of ADM (Klein, 1994).

Other predisposing factors include anatomical and
congenital abnormalities such as cleft lip and palate and
those children who have neuromuscular diseases such as

muscular dystrophy or generalized hypotonia. The increased

10
incidence of acute otitis media is related to the anatomical
differences and neuromuscular function in these children
(Klein, 1994; Facione, 1990).

Social factors that contribute to the increased
incidence of ADM are lower socioeconomic status, possibly
likely related to the availability of affordable healthcare
and the family's perceptions of the disease and education
levels (Facione, 1990). There may also be a relationship
between illness and cleaning practices. The lack of an
automatic dishwasher may result in inadequate cleaning of
bottles and cups. There are no specific data available for
exact reasons for this trend. Households with cigarette
smokers present and the prevalence of passive smoking leaves
the child at three times more at risk for developing ADM
(Facione, 1990).

Feeding practices also play a role in the development
of acute and recurrent otitis media. The reclined position
of the child during feeding combined with the immature
position of the eustachian tube increases the incidence of
ADM (Bonadio, 1994; Brook, 1994; Facione, 1990; Klein, 1994;
Agency for Health Care Policy and Research (AHCPR, 1994).
The benefits of increased mother to baby immunities as the
result of breast-feeding has been shown to be an important
factor in the prevention of respiratory infections,
including otitis media, in infancy. As a result, those
infants who are bottle-fed from birth may experience

increased incidence of ADM (AHCPR, 1994). The child's

ll
attendance in a large day-care setting has been shown to
increase the incidence of otitis media, respiratory and
gastrointestinal infections (Klein, 1994; Facione, 1990;
AHCPR, 1994).
El . J . E . l'

Acute otitis media is an inflammatory process of the
middle ear canal and its contiguous structures. It most
commonly occurs in conjunction with eustachian-tube
dysfunction, obstruction and impaired middle ear canal
ventilation. The most widely held theory regarding
pathogenesis of ADM is that the eustachian tube is
sufficiently obstructed to cause impaired middle ear canal
ventilation and result in the absorption of air, atelectasis
and development of persistent high negative pressure in the
middle ear canal. Transudation of plasma into the tympanum
and the middle ear canal is cased by the atelectasis. The
negative pressure gradient toward the middle ear canal
predisposes to reflux, aspiration and the insufflation of
nasal passage secretions into the middle ear canal.
Bacteria is then trapped and proliferates, resulting in
infection (Bonadio, 1994). Klein (1994), adds that the
acute episode of otitis media occurs from a sequence of
events. He explains that the patient has an antecedent
condition such as a viral or allergic reaction. This
condition results in the congestion of the mucosa of the
upper respiratory tract and in the eustachian tube that

results in obstruction of the tube. The secretions of the

12
middle ear have no avenue for escape. The secretions
accumulate, colonize and a resulting suppurative infection
occurs. Figure 1 is a depiction of this process.
Microbiology

It is important to understand the microbiology of acute
otitis media so that appropriate treatments can be carried
out. Knowledge of the pathogens responsible for otitis
media enable the most appropriate treatment regimen to be
selected and will minimize further complications (Brook &
Van De Heyning, 1994). The rationale for using antibiotics
is based on the presence of virulent bacteria in acute
otitis media.

Epidemiological and virological data show a powerful
association between the incidence of ADM and upper
respiratory infections (Bonadio, 1994). Upper respiratory
infections can impair the function of the eustachian tube
thus helping to create negative pressure in the middle ear,
and a suitable environment for the development of acute
otitis media (Brook & Van De Heyning, 1995). Viruses have
also been implicated as the infectious cause of acute otitis
media. According to Bonadio (1994), a viral isolate in the
middle ear effusion occurs in 10% to 25% of cases of ADM.
The most common viral etiological agents isolated in the
middle ear effusion of children with ADM are those that
cause upper respiratory epidemics, including the enterovirus

(Bonadio, 1994). Other viruses associated with ADM are

13

Elam-4. Pathophysiology of Otitis Media (Brook, 1994).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Infection: Eustachian
Allergy Bacteria Tube
Viruses Dysfunction
Mucosal
Swelling
. v
ET
Blockage
V
/ EfiUSiOH
_ v ' ‘
Acute OM L - Acute
/ V a Serous 4—9 Recovery
_ _ v \ a * \+
. Chronic! Chronic .
lfecovery Perforauon Recurrent l Serous <—> Muc01d
* _ A v
Chronic Chronic OM 3:23;:
OM r &Perf0rat10n 7 "Glue Ear" »
Cholesteatoma —> Complication

 

 

 

 

 

 

l4
respiratory syncytial virus, influenza A and influenza B,
rhinovirus, and adenovirus (Brook, 1994). The high rate of
unresponsiveness of ADM to antimicrobial therapy may be due
to the infection caused by virus rather than bacteria and
probably contributes to the chronicity, relapse and
frequency of the disease (Brook, 1994).

A bacterial pathogen is isolated from the middle ear
fluids of approximately two-thirds of children with acute
otitis media (Brook & Van De Heyning, 1994; Bonadio, 1994;
Newton, 1995; Klein, 1994; Brook, 1994). Studies differ
slightly in percentages, but three organisms are found most
often in the middle ear fluids. Streptococcus pneumoniae,
Haemophilus influenzae, and Moraxella catarrhalis are the
principle pathogens in acute otitis media (AHCPR, 1994;
Brook, 1994; Brook & Van De Heyning, 1994; Newton, 1995;
Mandel, Casselbrant, Rockette, Bluestone, Kurs-Lasky, 1995;
Paradise, 1995; Diven, Evans, Alper, Burckart, Jaffe, Doyle,
1995; Facione, 1990; Bonadio, 1994; Klein, 1994). The
general distribution of pathogens causing ADM according to
literature is represented in Table 3.

S I i E] . J E' i'

There is a range of common symptoms with which infants
and children suffering from ADM present. Based on Pearse
and Bridges-Webb (1993), infants commonly present with non-
specific symptoms such as fever, crying, and vomiting.

According to Pichichero (1994), it is extremely uncommon for

15

  
   

 

 

 

 

 

 

 

 

Table 3.
Dist:ibuticn_9f_2athesens
Patho en Distribution in % Resistant Bacteria
S. Pneumonia 30 to 35% N/A
H. Influenzae 20 to 22% 15-30% ampicillin
resistant
M. Catarrhalis 10 to 15% 75% are **beta-
lactamase
S. Pyogenes 5% N/A
S. Aureus
I Dther Bacteria 20 to 30%

 

 

 

**Beta-lactamase producing pathogens are of a particular
concern to the practitioner because its numbers are
increasing and it is resistant to most common antibiotic
treatment (Bonadio, 1994).

a child less than two and a half years of age to have the
ability to clearly express verbally that an ear ache is
present. Instead, parents often note other common
indicators of otalgia such as ear tugging, restlessness
during sleep, diminished appetite, irritability or
fussiness, runny nose and fever (Bonadio, 1994; Facione,
1990).

Based on Klein's work (1994), signs and symptoms of
acute otitis media include otalgia, otorrhea, hearing loss,
fever, irritability, headache, lethargy, anorexia or
vomiting. Klein (1994) adds that uncommon signs of ear
infection are tinnitus, vertigo and nystagmus. Facione
(1990) suggests that the prominent signs and symptoms of

acute otitis media are ear ache (otalgia), with worsening

ear pain at night. This is caused by increased vascular

l6
pressure in the reclined position causing the drum to bulge
painfully. Other manifestations include otorrhea,
presenting as a purulent and often foul-smelling discharge,
hearing loss, tinnitus, periauricular swelling and mild
balance disturbances (Facione, 1990).
Wine:

The acutely painful ear (or, in infants, the apparently
painful ear) is commonly assumed to be due to acute otitis
media but a precise diagnosis should be based upon the
physical exam. The most critical aspect of the physical
exam for exact diagnosis of acute otitis media is the
internal ear exam, or the otoscopic examination. According
to the AHCPR (1994) guidelines, pneumatic otoscopy must be
used for the diagnostic evaluation of otitis media. Bonadio
(1994) adds that it takes skill and practice to perform a
reliable otoscopic exam. The performance of the pneumatic
otoscopic exam may also be accompanied by technical
difficulties, such as inadequate patient compliance with the
procedure, an obstructed visual field or lack of uniform
pressure applied to the middle ear system. Pearse and
Bridges-Webb (1993) conclude that redness of the ear drum
without other symptoms is not conclusive for a diagnosis of
acute otitis media. Redness may be caused by other factors
such as prolonged crying or nasal congestion.

Klein (1994), suggests that four characteristics of the
tympanic membrane should be evaluated when pneumatic

otoscopy is performed. These are position, color, degree of

l7
translucency, and mobility. The normal tympanic membrane is
in a neutral position (neither retracted nor bulging),
pearly gray, translucent and responds quickly to positive
and negative pressure, indicating an air-filled space
(Klein, 1994).

Bonadio (1994), elaborates on the otoscopic
abnormalities that accompany acute otitis media. Bonadio
(1994) states:

“By examining the tympanic membrane and visible

contents of the middle ear canal, an inference is

made regarding middle ear canal status. Any

pressure differential existing across the tympanic

membrane results in stress applied to the tympanic

membrane. Although translucent, the tympanic

membrane can reflect inflammatory and barometric

changes in the middle ear canal? (p. 197).

Abnormal findings of the tympanic membrane as observed
by otoscopic examination and their related causes are
summarized in Table 4. The findings described in Table 4
are common tympanic membrane changes found through otoscopic
examination. Tympanometry has been used to assist in the
diagnosis of an air or fluid-filled middle ear space
(Bonadio, 1994; Klein, 1994). Tympanometry allow the
assessment of the compliance of the tympanic membrane and
provides an estimate of middle ear pressure. Tympanometry
uses an air pump to vary ear canal air pressure, thus

altering the stiffness of the tympanic membrane. A signal

18

Table 4.

I . H l E' i' [E i' 155']

 

 

 

 

 

 

 

 

Tympanic Abnosral
Membrane Findings Causes
1 ‘
Pearly grey TM inflammation or hemorrhage, middle ear
to red or canal purulent secretions, tympanic membrane
yellow/dark edema
grey
Clarity Opaque Tympanic membrane edema, middle ear canal
purulent effusion ro landmark obscurity
Contour Retraction Barometric changes in the middle ear canal
distention increased hydrostatic pressure
Mobility Pressure Middle ear effusion or atelectasis
changes

 

 

The findings described in Table 4 are common tympanic membrane changes
found through otoscopic examination.

is then transmitted into and through the tympanic membrane
and middle ear, reflected back in to the ear canal, and
received by a microphone. The tympanogram records air
pressure in millimeters of water and it also records TM
compliance (Bonadio, 1994; Klein, 1994).

Bonadio (1994) recommends the use of tympanometry to
objectively measure compliance of the middle ear system.
Bonadio (1994) notes that tympanometry can be reliably
performed in children as young as six months of age and it
is quite accurate in assessing middle ear effusion with a
82% to 90% accuracy rate.

The Agency for Health Care Policy and Research (AHCPR,
1994), published guidelines based on the largest literature
search and meta-analysis ever undertaken on otitis media.

The AHCPR (1994) guidelines are for the treatment of chronic

19
otitis media or otitis media with effusion and not for acute
otitis media, but some of the treatment and diagnostic
recommendations can be appropriately applied. AHCPR (1994)
does not recommend the use of tympanometry for routine
diagnosis of otitis media. AHCPR (1994) states the
tympanometry may be used as a confirmatory test as an
option.
I l l E E | :l'l' H 1'

Treatment recommendations for acute otitis media vary
from country to country and have changed over time.
Treatments are currently changing again because of the
emergence of beta—lactamase-producing bacteria in otitis
media. Thus, traditional choices in antibiotic therapy are
also beginning to give way to new options in antibiotic
therapy.

In the pre-antibiotic era, acute otitis media was
feared for its high incidence of serious morbidity and
mortality. There are several serious systemic complications
that can arise such as mastoiditis, labyrinthitis, brain
abscess, meningitis and bacteremia (Brook & Van De Heyning,
1994). In 1916, 85% of brain abscesses were due to
complications of otitis media as compared to 2.6% in 1990
(Facione, 1990). Acute otitis media was responsible for
mortality rates as high as 4% prior to the 1960's (Facione,
1990). Infectious complications like mastoiditis, central
nervous system abscess, and bacterial meningitis occurred in

as many as 20% of acute otitis media cases during the pre-

20
antibiotic era, but presently complicate less than 1% of
cases (Bonadio, 1994). The American Academy of Pediatrics
concur with this position and point to the severe
complications of otitis media seen prior to the advent of
antibiotics as a justification of an aggressive-treatment
policy (Facione, 1990).

In other countries such as the Netherlands, Scandinavia
and the United Kingdom acute otitis media is not treated
routinely with antibiotic medications (Facione, 1990;
Pichichero, 1994; VanBuchem, Knottnerus, & Peters, 1995).
The trend in these countries is to rely on the spontaneous
cure rate of acute otitis media that is as high as 14% to
88% without treatment (Pichichero, 1994; Newton, 1995).

When relying on a spontaneous cure, clinicians in these
areas consider symptomatic therapy such as pain medication,
as satisfactory and appropriate management of patients with
ADM (Facione, 1990; Newton, 1995; Pichichero, 1994). For
purposes of this project, information will be based upon the
treatment practices in the United States.

According to Bonadio (1994), “antibiotic therapy is
beneficial in treating acute otitis media by promoting the
eradication of bacteria, shortening the duration of symptoms
and period of morbidity, and preventing intracranial and
infratemporal suppurative complications? (p. 199). As
suggested by Pearse and Bridges-Webb (1993) the intent of
acute otitis media treatment should be to alleviate the

symptoms, eliminate the infecting agent, promote restoration

21
of normal hearing, and prevent recurrence, chronicity or
complications. Pharmacologic management of ADM should be
guided by considerations such as components including
medication cost, rate of adverse reaction, geographic
susceptibility patterns of organisms that cause acute otitis
media, and patient age and medical history (Bonadio, 1994;
Paradise, 1995). Based on Klein's (1994) research,
management of acute otitis media should include the elements
of comfort, microbiology, side effects, availability,
convenient dosing schedule, palatability and reasonable
cost. The antimicrobial agent should have a spectrum of
activity that includes S. Pneumoniae and H. Influenzae and
documented clinical and microbiological efficacy (AHCPR,
1994; Bonadio, 1994; Brook, 1994; Canafax & Giebink, 1994;
Facione, 1990; Klein, 1994; Pichichero, 1994; Paradise,
1995). Clinical efficacy should be measurable based on
substantial resolution of signs and symptoms within 48 to 72
hours and prevention of relapse, recurrence, and suppurative
sequelae (Klein, 1994).

Klein (1994) recommends that the oral drug should be
palatable in terms of smell, texture, taste, and after
taste. In the 6 to 36 month age group, this is especially
relevant. Dosage scheduling should be appropriate and
convenient for the family. A once or twice-a-day dosing is
preferable and increases compliance with the prescribed
regimen by both the child and the parents. Toxicity has

been found to be rare with the current approved roster of

22
drugs indicated for ADM, but any side effects should be
limited in incidence. Cost is also an important factor when
prescribing the appropriate drug. A high population living
in the United States do not have prescription insurance
coverage and are forced to pay out-of-pocket for their
medicines which can be very costly (Klein, 1994).

The 11 currently antimicrobial agents with their costs,
palatability, dosages and trade names are listed in Table 5.
The cost information was obtained from a Meijers pharmacy
that has stores state wide throughout Michigan. The costs
that are quoted are accurate as of December, 1996. Based on
the information provided in Table 5, it is apparent that
there are many choices of antimicrobial therapy for
treatment of acute otitis media. If cost is an issue with
the client's family, there are several low cost choices that
may be suitable for treatment.

CanenLRecgmmendatigns

Based on current research, the most common pathogens
implicated in acute otitis media are S. Pneumoniae, H.
Influenzae and M. Catarrhalis and most patients with these
bacterium isolated from middle ear effusion do respond
favorable to amoxicillin (AHCPR, 1994; Brook 8 Van De
Heyning, 1994). From a study published in 1991, there were
fewer treatment failures among patients receiving
amoxicillin (p=0.009) than in those given placebo (Kaleida,
Casselbrant, Rockette, Paradise, Bluestone, Blatter,

Reisenger, Wald & Supance, 1991).

23

        

    

    

 

  
  
 
  
   
 
  
   
 
  
 

 

 

 

 

 

 

 

 

 

 

   
 

 

Table 5.
W1
Generic Name Trade Name Dosage Cost (for Palatability
10 days) Rankin
Amoxicillin Amoxl 40mg/kg TID $8.99 5th
. trimox
Amoxicillin/ Augmentin. 20mg/kg TID $68.20 3rd
clavulanate
I Cefaclor Ceclor 20mg/kg BID $38.15 2nd
I Cefixime Suprax 8mg/kg QD $67.45 1st
Cefpodoxime Vantin 10mg/kg BID $23.08 no info
proxetil
Cefprozil Cefzil 30mg/kg BID $70.59 no info
Clarithromycin Biaxin 7.5mg/kg BID $65.72 no info
Erythromycin Bactrim 30-60mg/kg $6.68 6th
sulfamethoxazole BID
Loracarbef Lorabid 30mg/kg BID $73.95 no info
Erthromycin- Pedizole 40mg/kg TID $5.05 4th
sulfisoxazole 1-

 

 

 

 

Increasing numbers of beta-lactamase resistant bacteria
has been found in H. Influenzae and M. Catarrhalis. This
has effected the efficacy of amoxicillin. Despite this
development, based on the review of literature, amoxicillin
remains the drug of choice for the treatment of acute otitis
media because of its 20-year record of clinical success.
Amoxicillin is palatable, has limited side effects and
relatively low in cost (Physicians Desk Reference, 1996;
Bonadio, 1994; Klein, 1994). Amoxicillin also has a low

expected clinical treatment-failure rate in children (Klein,

24
1994). As a result of these factors, amoxicillin is the
most commonly prescribed “first-line” antibiotic for
uncomplicated acute otitis media and multiple studies have
continued to document positive clinical outcomes in those
patients receiving amoxicillin (AHCPR, 1994; Bonadio, 1994;
Brook, 1994; Canafax & Giebink, 1994; Pichichero, 1994;
Paradise, 1995).
When:

The duration of antimicrobial therapy for treatment of
acute otitis media is based on traditions and is being
questioned by many clinicians and researchers. According to
Mandel et al. (1995), the optimal length of antimicrobial
administration for treatment of ADM is not know. Standard
textbooks recommend a 10-day course of treatment (Emergency
Diagnosis and Treatment, 1992; Diseases, 1997). Studies
that have been done to test shorter and longer durations of
treatment yield more questions than definitive answers.

Traditionally, the recommended duration of antibiotic
therapy for ADM is 10 days. This was established as
necessary for optimal bacteriologic eradication for Group A
beta-hemolytic streptococcal in tonsillopharyngitis and then
became the empirical standard for virtually all outpatient
antimicrobial regimens in the United States (Pichichero,
1994). In an American study that compared 5 versus 10 days
of antibiotic treatment, patients without otorrhea had
similar response to both regimens. However, patients with

otorrhea had significantly higher treatment failure rate

25
with the shorter regimen (Pichichero, 1994). Three studies
have demonstrated that bacteriological cure of ADM occurs
after three to six days in 85% to 95% of those treated with
amoxicillin (Sato, Quartey, Liebeler, & Giebink, 1995).
Hendrickse and Kusmiesz (1988) showed equivalent acute
otitis media clinical cure rates in those receiving 5 rather
than 10 days of oral antibiotics for uncomplicated acute
otitis media. Another study showed similar rates of
symptomatic improvement, signs of hearing loss and rates of
recurrence of ADM in those patients receiving a 3-day course
of treatment rather than the traditional 10-day course of
amoxicillin therapy (Caput, Levine & Savage, 1992). Most
researchers and clinicians agree that 10 days is a longer
period than necessary for many children but it may be
shorter than necessary for others. Paradise (1995) supports
an individualized treatment duration based on each patients
severity of infection, the child's previous history of
otitis media and their response to current therapy. Mandel
et al. (1995) performed a trial to see whether treating for
20 days instead of the traditional 10-day treatment period
would improve the results of treatment. The study was
performed over a three year period and was based on 267
children with uncomplicated otitis media. The authors
concluded that they do not recommend the routine use of an
additional 10-day course of antimicrobial treatment if a
child is symptom-free after the initial 10 days of treatment

for ADM (Mandel et al., 1995).

26

The duration of antimicrobial treatment continues to be
debated (Brook & Van De Heyning, 1994). The current
recommendations are for a 10 day duration of antimicrobial
therapy until further studies are available that may yield
more definitive options based on clear and statistically
powerful data.
Treatment_Alternatixes

Based on factors of side effects, palatability, dosage
schedule, convenience, cost, compliance and availability,
the clinician can prescribe any of the 11 approved drugs for
ADM. Less frequent dosing schedules have been shown to
improve compliance (Paradise, 1995). Side effects of
medications have also been known to decrease patients
compliance to medications. Amoxicillin has been documented
to have the least amount of side effects from the field of
approved antimicrobials (Bonadio, 1994). Cefaclor has been
shown to have a propensity to produce a serum sickness-like
reaction and the latest trials have shown that the efficacy
of cefaclor is lower than other antimicrobials (Pichichero,
1994). Amoxicillin—clavulanate and erythromycin have both
been shown to produce diarrhea as a side effect, but this
can be reduced by taking the medication with meals
(Pichichero, 1994).

Some of the newer cephalosporins, such as suprax,
vantin and lorabid, have more convenient dosing schedules
and have superior palatability, but as seen in Table 5,

these drugs also tend to be more expensive. Cefixime, for

27
example, has a once-a-day dosing schedule which would tend
to increase patient and caregiver compliance to the
treatment regimen, but the cost of cefixime is significantly
higher than amoxicillin (Meijers Pharmacy, 1996).

The most important reason to choose an alternative
antimicrobial agent is the bacteria's resistance to the
first-line antibiotic. According to Paradise (1995),
choosing a beta-lactamase resistant drug alternative should
be based on the heightened risk of a beta-lactamase
producing pathogen or if the clinician feels that the
patient is in urgent need of prompt relief. Also, if there
has been a community-wide trend towards a beta-lactamase-
producing pathogen, an alternative such as augmentin should
be chosen (Paradise, 1995). .Dther circumstances for
choosing a stronger medication include symptoms that persist
for more than 48-72 hours after using amoxicillin and an
episode within the last two months that failed to respond to
amoxicillin. One might choose to treat with a beta-
lactamase resistant drug from the outset if the patient is
immunocompromised in any way or if symptoms are exceedingly
severe (Paradise, 1995).

Other treatments such as decongestants, antihistamines
and oral steroids have been used in the treatment of ADM.
Bonadio (1994) states:

“..in patients with either symptomatic or

asymptomatic acute otitis media with middle ear

effusion, the administration of decongestant/

28

antihistamine medication has not been shown to

hasten symptomatic improvement, middle effusion

resolution, or prevent acute otitis media when

initiated at the onset of upper respiratory

symptoms” (p. 202).

According to the AHCPR (1994) guidelines, the panel of
experts concluded that steroids, decongestants and
antihistamines did not effect the resolution of acute otitis
media. Paradise (1995), also agrees that a combination of
antihistamines and decongestants have been discredited and
are ineffective in the treatment of ADM and evidence that
mucolytic agents are effective is not convincing. The
literature abounds with conflicting studies, but most
studies seem to question the value of these medications
rather than support their use.

The efficacy of steroids, either systematically or
intranasally, for acute otitis medial also remains uncertain
(AHCPR, 1994; Paradise, 1995). It is noted that in cases
when a child has not had a varicella, the use of steroids
carries life-threatening risks of varicella should develop
(Paradise, 1995). According to Klein (1994), there is
little evidence suggesting that a course of systematic
corticosteroid therapy combined with an antimicrobial agent
is of value. Conversely, Rosenfeld (1995), states that
combining an antibiotic with an oral steroid when treating

ADM with effusion appears “promising”, but at this time,

29
cannot be recommended secondary to sparse and inconsistent
evidence which lack statistical significance.

Topical anesthetic drops are frequently used for
children with painful acute otitis media. It is noted that
these preparations should never be used for ADM with
tympanic membrane perforation because the medication may
enter the middle ear canal (Bonadio, 1994).

Dtalgia is a common symptom of acute otitis media and
current literature supports pain control in the form of
acetaminophen with codeine for severe pain and plain tylenol
or ibuprofen for mild to moderate pain and fever (Bonadio,
1994).

Refernauriiericn

Follow up recommendation vary relative to the
appropriate time for the follow up visit. Hathaway, Katz,
Deshewitz, and Marx (1994), cite a recent survey of
pediatricians and nurse practitioners with the standard
range for follow up being 10 days to 6 weeks. Follow up is
essential in order to detect persistent pathology or hearing
loss. According to Paradise (1995), follow-up for the non-
complicated case of acute otitis media to be one month. At
that visit, Paradise recommends an exam with a tympanogram
to indicate whether the otitis has resolved completely.

Those patients with persistent effusion after four
months need a referral to an ear, nose and throat specialist
for consideration of myringotomy, tympanostomy tubes or

adenoidectomy (Pearse & Bridges-Webb, 1993). Other referral

30

criterion: a) infants and children who have more than three
episodes of acute otitis media within six months should be
referred to the otolaryngologist; b) five or six episodes of
otitis media in one year's time; c) the persistence of
supportive infection despite antibiotic therapy; d) an
effusion that persists for several months and becomes mucoid
in nature (Brook, 1994; Facione, 1990). The AHCPR (1994),
recommend a referral if an effusion has lasted a total of
three months. The 1992 Clinical Indicators Compendium
prepared and published by the American Academy of
Dtolaryngology, suggests a three-month waiting period for a
child with persistent middle ear effusion prior to a
referral from the primary care clinician to the
otolaryngologist. Referrals are made because of prolonged
periods of middle ear effusion and frequent episodes of
acute otitis media can result in degraded language input and
conductive hearing loss (AHCPR, 1994). Research has shown
that there is an association between recurrent ADM in the
preschool years with subsequent linguistic, cognitive and
academic impairment. These complications are especially
prevalent in those children with the onset of middle ear
effusion during the first 12 months of life (Bonadio, 1994).
Enexentign

Some general principles can be applied in the
prevention of ADM and these principles should be the basis
of patient education. Breastfeeding has been found to

provide some degree of protection, although this is not

31
absolute (AHCPR, 1994; Paradise, 1995). Educating the
caregiver on bottle feeding position may also assist in
decreasing the chance of ADM. Correct bottle feeding
position is at an incline or sitting position; therefore
decreasing fluid going into the middle ear. Dther
suggestions include enrolling children in small, rather than
large, group day care centers, maintenance of good general
hygiene and avoiding exposure to infectious disease (AHCPR,
1994; Klein, 1994; Paradise, 1995). Data concerning the
role of tobacco smoke exposure playing a possible role in
the pathogenesis of acute otitis media is not yet firm, but
avoidance is most certainly worthwhile in the light of its
role in the causation of upper respiratory diseases (AHCPR,
1994; Paradise, 1995).

Clinicians should also advise parents of the seasonal
incidence of acute otitis media and the expectation that the
child's condition may improve in the late spring and summer
months. Aggressive treatment and management may be
postponed until the course of disease has been determined in
the following respiratory season (Klein, 1994).

Chemoprophylaxis has also been shown to be successful
in reducing the number of new episodes of acute otitis media
in children who have a history of recurrent infections.
There has been a 40% to 88% success rate in the reduction of
recurrent episodes if the child was treated with
prophylactic antimicrobial therapy (AHCPR, 1994; Klein,

1994).

32
Summary

Dtitis media is the most common respiratory tract
infection of infants and early childhood. A bacterial
pathogen can be isolated from approximately 65% of children
with ADM. The three most common pathogens are S.
Pneumoniae, H. Influenzae, and M. Catarrhalis.

A pneumatic otoscopic exam should be used to diagnose
acute otitis media and tympanometry is a helpful adjunct
tool to confirm the diagnosis. Common symptoms are fever,
irritability, crying, loss of appetite, pulling at ear,
otorrhea, otalgia, nausea and vomiting. Common physical
findings are tympanic membrane redness, bulging, retraction,
dullness opaqueness, perofrmation, purulent drainage and
indicative tympanometry readings.

The treatment most often recommended in the United
States is a 10-day course of antimicrobial therapy with
amoxicillin. If a beta-lactamase-resistant pathogen is
suspected or if symptoms and presentation are severe,
amoxicillin-clavulanate is recommended with a 10-day course
of treatment. Factors to be aware of when prescribing
alternative antimicrobial therapy are cost, compliance,
palatability, efficacy, dosage schedule and side effects.

Referrals are based on persistent middle ear effusion
and frequent recurrent episodes of acute otitis media.
Prevention is based on environmental and social issues and
the use of Chemoprophylaxis has been effective in reducing

recurrent episodes of acute otitis media.

33

The literature has presented much uncertainty in the
duration of antimicrobial therapy in the treatment of ADM.
Studies have suggested further investigation in regard to
the use of decongestants, antihistamines and steroid
therapy. There are also discrepancies in the ideal time to
follow up and referral to otolaryngologists and ear, nose
and throat specialists.

Critical Pathway

Based upon the literature review and the scope of
practice from which the Nurse Practitioner functions, a
critical pathway for infants and toddlers, ages 6 to 36
months is suggested for an APN working in the primary care
setting. The review of literature has revealed the most
commonly accepted practices when treating acute otitis media
in this age group. This practice will be condensed and
applied to the non-complicated patient ages 6 to 36 months
presenting to the primary care setting with the complaint of
acute otitis media. The therapeutic interventions and
treatment plan are based on the literature review.
Interaction with the client and family, along with care
provided, will be given in an organized and logical sequence
based on the APN dimensions of practice from the American
Nurses Association nurse practitioner scope of practice
(ANA, 1985).

The critical pathway (Table 6) will be presented in the
form of what content that must be accomplished within a 15

minute visit to the primary care setting. Follow up and

34
Table 6.
E' lll' '! I ll EEII

 

 

Assessment Thorough focused patient and family medical history
current medications; developmental milestones; allergies
and reactions; immunizations; past illnesses; familial
history.

History of present illness

-onset, duration, symptoms, what alleviates symptoms, what
worsens symptoms, sequelae.

Social history/Feeding history

-breast or bottle fed

Environmental history

-home environment;

-other children ill in the home or day care;

-day care (size of day care)

Strengths of patient and family/Coping skills/Physical
examination

-vital signs with temperature, thorough pneumatic
otoscopic exam. Thorough head and neck examination,
throat exam, cervical node exam. Full respiratory exam
along with auscultation of heart and lung sounds.

 

Diagnosis Impression based on history

-irritability, fever, pulling at ears, sleeplessness
Diagnosis based on history and exam

-pneumatic otoscopy: Dull, retracted, bulging, non-mobile
tympanic membrane, erythema.

-tympanometry may also be helpful when diagnosing middle
ear effusion and can be used as an adjunct to pneumatic
otoscopy.

 

 

Plan Treatment:

-Tylenol or children's ibuprofen per weight for pain
control Amoxicillin suspension 40mg/kg/day in divided
doses for 10 days.

-If symptoms are severe: Start with Amoxicillin-clavunate
40mg/kg in divided doses for 10 days.

-If allergic to penicillin: Give appropriate alternative
antibiotic from the list of 11 approved antimicrobials.
-Follow up in office in 48-72 hours if no improvement.
-Follow up in 10 day in the office for recheck of symptoms
Education:

-correct medication administration and dosage of tylenol ,
and ibuprofen. i
-therapeutic feeding methods for bottle feeding.

-signs of improving and worsening symptoms

-discussion of smoking habits or day care if applicable
Expected outcomes:

-meds taken in compliance to plan

-total resolution of symptoms

 

35
evaluation of interventions will be the second 15 minute
visit. Table 7 shows the critical pathway for the possible
return visit in 48 to 72 hours. Table 8 is the critical
pathway for the 10 day return visit.
C 'l' ] E I] E J l'

The evaluation of the critical pathway is performed by
evaluating the outcomes of the interaction and the
interventions that were carried out. Another aspect of
evaluation is the APN's satisfaction with organization of
the pathway and whether it meets the needs of the target
population and the goals set forth by the APN. The
pathways' focus was to provide a logical and sequential set
of actions based on what is currently known about acute
otitis media and its treatment. The purpose of an
evaluation is to assess the outcomes of treatments and
interventions.

Initial evaluation of the critical pathway takes place
during and after the first visit with the client and their
family. The APN should mentally note if he/she felt the
interaction was positive and that the parental caregiver
comprehended the instructions. The APN should note if there
was a satisfactory amount of time for questions and answers
and a good rapport was initiated with both the parental
caregiver and the child.

Ongoing evaluation continues at the 48 to 72 hour
period when the patient was to return if symptoms had not

improved. If the patient does return, this outcome is

36

       
   
   

Assess Thorough physical exam and history of continued illness.
Assess appropriateness of original plan.

Plan If symptoms have persisted without improvement and there are:
no new symptoms or source of infection:
Treatment:
-Change Amoxicillin to Augmentin 40mg/kg/day in divided
doses for a duration of 10 days.
-May consider using other approved antibiotics that are
known to have a strong efficacy against beta-lactamase
resistant bacteria (Example: vantin, cefzil, lorabid,
biaxin).
-Advise parent to have child recheck if no improvement of
symptoms within 48 hours.
-Return in 10 days for recheck to evaluate for full

resolution of symptoms.
Education:

-reinforce previous teaching.
3 l—

 

 

 

   

-Perform complete pneumatic otoscopy evaluate for full
resolution of symptoms.

-If symptoms have not resolved, consult physician.
Consider ONE:

-If symptoms of OMB do not resolve within one month.

-Treat DME par AHCPR guidelines

Evaluate

 
   
   
 
  

 

 

 

positive in terms of compliance and the recognition on the
part of the parental caregiver that symptoms were still
present. At this visit, it is important to assess whether
the parental caregiver gave the medication correctly and
timely.

Final evaluation of the pathway takes place at the 10-

day return visit. The patient is assessed by pneumatic

37
otoscopy. The tympanic membrane should be without signs of
effusion or continued infection. The patient should be
without any signs of sequelae.

The parental caregiver should report that the
medication was given as prescribed at the previous visit.
Dther expected outcomes such as bottle-feeding technique
should also be evaluated for further teaching or parents
verbalization of complete understanding. Any other teaching
or issues that were addressed at the initial visit should be
evaluated and discussed based on the expected outcomes that
were established for each issue.

Finally, the APN should critique the critical pathway
in terms of logic, organization and appropriateness to the
targeted population. The APN should also evaluate whether
the pathway provided for continuity and comprehensiveness.
These aspects of evaluation would be on-going as the APN
sees patients for the chief complaint of acute otitis media.
With each case, the APN should not whether or not the
pathway was appropriate and met its goals and any aspects
that should be modified.

Further evaluation of the pathway can be accomplished
through a chart audit. Information from the chart audit can
evaluate if the pathway was used and the outcome of illness.
The chart audit can indicate if the patients' symptoms
resolved and how many patient's follow up.- Another

important evaluation is to find out how many children

38
developed chronic otitis media after treatment with the use
of the critical pathway.
I J' l' E I] EEH

Acute otitis media is the most common outpatient
complaint that children present to the primary care setting.
The APN will most assuredly come into contact with and treat
many children with this complaint. Based on this premise,
it may be helpful to the APN to have a logical, formatted
critical pathway to work form based on the latest in acute
otitis media research and practice guidelines.

From the standpoint of advanced practice and primary
care, the pathway will uphold the goals of primary care
which include continuity and comprehensiveness (Starfield,
1992). The pathway provides continuity by allowing an
uninterrupted succession of events. Continuity is achieved
through the progression of the pathway and the documentation
of expected outcomes and the evaluation of these goals.
Comprehensiveness is achieved through the actions of the
direct advanced practice nursing care roles or dimensions
(ANA, 1985). The critical pathway is comprehensive in its
holistic structure and evaluation components. Finally, the
pathway is comprehensive because of the referral component.
This provides a full range of services available to the
client if necessary (Starfield, 1992).

The critical pathway may also prove to be cost
effective in terms of efficiency. The pathway for the visit

it organized and sequential. There is a logical progression

39
of events within the patient's visit. This maintains the
course of the visit in goal-directed pattern of events and
maintains focus throughout the interaction, resulting in a
time efficient visit. Time lost in clinic settings means
increased costs and lost revenue. The critical pathway
allows for a timely and holistic treatment process while
still focusing on all aspects of the client's needs.

Dther implications include the APN's involvement in the
process and on-going development of the critical pathway.
The APN is in the position to critique and modify the
pathway to best suit the needs of the population he/she
serves. The APN also plays an integral part in the
evaluation process.

Implications of the pathway may include education for
other APN's as well as APN students. The pathway is easy to
follow and may assist APN students in their grasp of the
subject. The pathway can also be discussed at an APN peer
review session, this may prompt even further exploration of
implications and use of the pathway.

Dther clinic setting implications could be the
incorporation of the medication chart for clinical
application. The chart would have to be routinely updated
in regards to the medications and latest costs. The
medications used in the pathway may also be used as a
standing order agreement in the collaborative agreement

between the physicians and the APN.

40

Finally, the APN should be motivated to be involved in
the latest trends related to the pathway and keep abreast of
current research. The APN may also be involved in the
research based on the possible outcomes of implementing a
critical pathway. Success of the acute otitis media pathway
may prompt the APN to be a researcher and create other
pathways for frequently seen common complaints in the

primary care setting.

LIST OF REFERENCES

LIST OF REFERENCES

Agency for Health Care Policy and Research. (1994).

Washington, DC.

American Academy of Nurse Practitioners (1993). agape
. Washington, DC.

American Nurses Association (1985). The_sggng_nf

WWW ' . . I
Washington, DC.

Bonadio, W. (1994). Otitis media: Microbiology and

management - www.193-
206 .

Brook, I. (1994). Dtitis media: Microbiology and
management. NW. 269-275.

Brook, 1., & Van De Heyning, P. (1994). Microbiology

and management of otitis media. Scandinaxian_unixg;ai;y
w, 20-32.

Canafax, D., & Giebink, G. (1994). Antimicrobial

treatment of acute otitis media. Annals_nf_thlngy‘
W191. 11-14 .

Chaput, D., Levine, D., & Savage, I. (1995). Trial of
3-day and 10-day course of ampicillin in otitis media.

W. 1078- 81.

Casselbrant, M., Mandel, E., Kurs-Lasky, M., Rockett,

H., & Bluestone, D. (1995). Dtitis media in a population of
black American and white American infants, 0-2 years of age.
. ‘ .- e.- e '. e "e. o O a a .e ; .ee as

1-16.

I

Diven, W., Evans, R., Alper, C., Burckart, G., Jaffe,
R., & Doyle, W. (1995). Treatment of experimental acute
otitis media with ibuprofen and ampicillin. International

MW, 127- 139.

Facione, N. (1990). Dtitis media: An overview of acute

and chronic disease. Nnrse_2ragtitinner+_15(10), 11-20.

Hathaway, T., Katz, H., Dershewitz, P., & Marx, T.
(1994). Acute otitis media: Who needs posttreatment follow

UP? W9), 143-147.

41

42

Hendricks, W., Kusmiesz, H., & Shelton, S. (1988).
Five versus ten days of therapy for acute otitis media.

Jeurnal_Qf_2ediatric_niseasesi_l 14- 23.

HO. M- (1992). Emer9enc¥_Diagnnsis_and_Treatment.
Appleton and Lange: Norwalk, CN.

Kalieda, P., Casselbrant, M., Rockette, H., Paradise,
J., Bluestone, C., & Blatter, M. (1991). Amoxicillin or
myringotomy or both for acute otitis media: Results of a

clinical trial, 2ed1ntz1251_81, 466-474.

Klein, J. (1994). Otitis media. gliniga1_1nfegtinns
Diseasesl_12. 823-33-

Mandel, E., Casselbrant, M., Rockette, H., Bluestone,
C., & Kurs-lasky, M. (1995). Efficacy of 20-versus 10-day
antimicrobial treatment for acute otitis media. 2ed1atrig§1
25, 5- 13.

Newton, A. (1995). The follow up of acute otitis media
in general practice.

SBZIiQ£+_&l 127'134-

Paradise, J. (1995). Treatment guidelines for otitis
media: The need for breadth and flexibility. J9nznal_nf

Pediatric_Infectieus_niseasesi_14 429- 35.

Pearse, P., & Bridges-Webb, C. (1993). Dtitis media in
general Practice. The_Medical_Isurnal_9f_Australia1_158.
542-543.

Pichichero, M. (1994). Assessing the treatment
alternatives for acute otitis media. Jnnrnal_gf_2edintzig
Infections_niseaseai_14, 527-34.

Rosenfeld, R. (1995). What to expect from medical
treatment of otitis media.

Diseasesi_14, 731-38.

Starfield. B- (1992) Brimaz¥_care1_ccncenti
Egnlnnt1nn_nnd_2nligy. Oxford University Press: New York.

Teele, W. (1980). Epidemiology of otitis media in
children. '
82, 5-6.

Van Buchem, F., Peeters, M., & Knottnerus, J. (1995).
Dtitis media in children.
,111(17), 1151-52.

CRITICAL PATHWAY FOR ACUTE OTITIS MEDIA IN
INFANTS AND CHILDREN (AGES 6-36 MONTHS)

BY
Maya Clark

AN ABSTRACT OF A SCHOLARLY PROJECT
Submitted to
Michigan State University
in partial fulfillment of the requirements
for the degree

MASTER OF SCIENCE IN NURSING

College of Nursing
1996

Sharon King, PhD, RN

ABSTRACT

CRITICAL PATHWAY FOR ACUTE OTITIS MEDIA IN
INFANTS AND CHILDREN (AGES 6-36 MONTHS)

BY
Maya Clark

Dtitis media is one of the most common pediatric
diseases. Approximately 7 out of 10 children are afflicted
and this includes children from all races, ages and social
groups (Bonadio, 1994). Acute otitis media (ADM) is the
most common specific diagnosis made by clinicians treating
youngsters in primary care family practices and pediatric
settings. The highest incidence of disease occurs between
the ages of 6 to 36 months (Bonadio, 1994). Complications
of acute otitis media and its sequelae often affect the
child years beyond the original infection in the form of
learning and speech disabilities and hearing deficits.

There is a need for consistent, holistic, low cost and
effective treatment of acute otitis media in the primary
care setting to treat the initial disease, establish
continuity with follow up and decrease the incidence of
morbidity related to chronic otitis media. The purpose of
this project is to develop a logical, research-based pathway
for practitioners working in primary care for infant and
toddler-aged patients presenting with uncomplicated episodes

of acute otitis media.

 

302374 9900 .